From the Wires
Medivation Announces Participation at Upcoming Investor Conference
By: Marketwired .
Feb. 6, 2013 04:10 PM
SAN FRANCISCO, CA -- (Marketwire) -- 02/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
SOA World Latest Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week